Vanderbilt University Medical Center

Essais liés27clinical trials

VilleNashvillelocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05372159

Ouvrir le site du centre

Essais cliniques associés

Molécule	Indication / population	Phase	NCT	Titre	Statut
Theophylline ER	SEP	Phase 2	NCT04240821	Theophylline for Treatment of Pseudohypoparathyroidism	ENROLLING_BY_INVITATION
Ocrelizumab	SEP	Phase 4	NCT04377555	Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab	COMPLETED
AADvac1	Alzheimer	Phase 2	NCT07167966	ATP — Alzheimer's Tau Platform: Regimen A - AADvac1	ENROLLING_BY_INVITATION
AADvac1	Alzheimer	Phase 2	NCT06957418	ATP — Alzheimer's Tau Platform: Master Protocol	RECRUITING
Baricitinib 4 MG	Alzheimer	Phase 3	NCT05858515	REVERSE-LC — REVERSE-Long COVID-19 With Baricitinib Study	WITHDRAWN
RO7046015	Parkinson	Phase 2	NCT03100149	PASADENA — A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease	ACTIVE_NOT_RECRUITING
Inavolisib	Cancer	Phase 3	NCT06790693	INAVO123 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer	RECRUITING
BHV-7000	Épilepsie	Phase 2/3	NCT06132893	RISE 2 — A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy	RECRUITING
Semaglutide (Rybelsus®)	Myopathies	Phase 1/2	NCT07642635	Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy	NOT_YET_RECRUITING
VMAP — Vanderbilt Memory and Aging Project	Alzheimer	À vérifier	NCT05372159	VMAP — Vanderbilt Memory and Aging Project	ACTIVE_NOT_RECRUITING
bemdaneprocel	Parkinson	Phase 3	NCT06944522	exPDite-2 — A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease	RECRUITING
Prasinezumab	Parkinson	Phase 3	NCT07174310	PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease	RECRUITING
ASSESS ALL ALS Study	Sclérose latérale amyotrophique	À vérifier	NCT06578195	ASSESS ALL ALS Study	RECRUITING
SGLT-2 inhibitor	Myopathies	Phase 1	NCT07172971	CHERISH — Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy	RECRUITING
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials	Myopathies	À vérifier	NCT07674758	Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials	RECRUITING
Litifilimab	Lupus	Phase 2/3	NCT05531565	AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus	ACTIVE_NOT_RECRUITING
RAP-219	Épilepsie	Phase 3	NCT07594119	FOCUS 2 — Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures	RECRUITING
EEG	Épilepsie	Non applicable	NCT06934356	Subcortical Arousal in Perceptual Awareness	RECRUITING
XEN1101	Épilepsie	Phase 3	NCT05718817	X-TOLE4 — An Open-label Study of XEN1101 in Epilepsy	ENROLLING_BY_INVITATION
Midodrine	Parkinson	Phase 1	NCT04620382	Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients	COMPLETED
Pimavanserin	Parkinson	Phase 4	NCT05357612	Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases	RECRUITING
Natalizumab 300 MG in 15 ML Injection	SEP	Phase 4	NCT05177718	Natalizumab and Chronic Inflammation	TERMINATED
Trimethaphan	Hypertension	Phase 1	NCT02726711	Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic	ACTIVE_NOT_RECRUITING
Renal Denervation (Symplicity Spyral™)	Hypertension	Non applicable	NCT05198674	SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN	ACTIVE_NOT_RECRUITING
Zilucoplan	Sclérose latérale amyotrophique	Phase 2/3	NCT04297683	HEALEY ALS Platform Trial - Master Protocol	ACTIVE_NOT_RECRUITING
Fenebrutinib	SEP	Phase 3	NCT04544449	FENtrepid — A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis	ACTIVE_NOT_RECRUITING
eculizumab	Myasthénie	Phase 2	NCT00727194	Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis	TERMINATED